Fingolimod Chemical Structure (Gilenya 01)
Gilenya Capsule
Product Images NDC 0078-0607
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Gilenya (NDC 0078-0607). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 Time To 3-month Confirmed Disability Progression – Study 1 (itt Population) (Gilenya 02)
Principal Display Panel Gilenya 0.5 mg 30 Capsules (Gilenya 03)
GILENYA (fingolimod) capsules with a strength of 0.5mg is an equivalent of 0.056 mg fingolmod hysrochloride. Each package contains 30 capsules and should be dispensed with the enclosed Medication Guide. The manufacturer is NovatsPiama San A5, St Switaand, and it is distributed by Novats afmaraytialsCopratin. Storage should be done at 2°C to 25°C, with excursions permitted to 0 15°C 103 G 35, Prototrom moisare. For more information, consult GILENYA’s official website.*
Principal Display Panel Gilenya 0.25 mg 7 Capsules (Gilenya 04)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
